The European Commission signs an agreement with Novavax to purchase 200 million doses of its protein-based COVID-19 vaccines, including an option to purchase another 100 million doses through 2023. (Politico Europe) European Union response to the COVID-19 pandemic, COVID-19 vaccineCOVID-19 pandemic in EuropeCOVID-19 pandemic link embed save